The Power of Non Traditional KOL Engagement

Nontraditional KOL engagement, Medical Science Liaisons strategies, personalized communication in healthcare, compliance in KOL interactions, empathy in healthcare relationships

In this episode, Tom Caravela is joined by Lindsey Harrer to discuss the power of non traditional Key Opinion Leader (KOL) engagement for Medical Science Liaisons (MSLs). They explore the differences in KOL interactions, strategies for aligning MSL objectives with KOL needs, and the importance of pe…

Apr 22^nd • 29 mins listen

Season 1, Episode 9: Career Insights From a CEO with Mark Erlander

We are thrilled to welcome Mark Erlander PHD, CEO of Cardiff Oncology, shares his journey from a PhD in neuroscience to leading an oncology company. He discusses the calculated risks he took throughout his career and the importance of following your passion. Erlander emphasizes the need for leaders …

Apr 15^th • 30 mins listen

Rethinking How We Track and Treat Cancer

Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13^th • 19 mins listen